Research Keyword: antimicrobial susceptibility

Clinical Isolate of Candida tropicalis from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of Ganoderma lucidum

mycolabadmin

Researchers in North Carolina identified a drug-resistant yeast infection (Candida tropicalis) from a hospital patient and tested whether extracts from reishi mushrooms (Ganoderma lucidum) could kill it. Using genetic analysis, they found mutations in the yeast that help it resist antifungal drugs. All three types of mushroom extracts tested successfully stopped the yeast’s growth and damaged its cells, suggesting that reishi mushrooms could be a promising natural treatment option for hard-to-treat candida infections.

Read More »

Antifungal Effects of Pterostilbene on Candida albicans, Candida dubliniensis, and Microcosm Biofilms of Denture Stomatitis

mycolabadmin

Pterostilbene, a natural compound found in blueberries and grapes, has been shown to effectively kill Candida fungi that cause denture-related mouth infections. In laboratory tests, it successfully eliminated fungal cells and disrupted harmful biofilms within 8 hours. When tested in a living organism model, pterostilbene proved safe and reduced infection severity, suggesting it could be a promising natural alternative to conventional antifungal medications.

Read More »

Peritoneal dialysis-related peritonitis caused by Fusarium: a case report and literature review

mycolabadmin

A 61-year-old farmer with kidney disease on peritoneal dialysis developed a rare fungal infection caused by Fusarium, a fungus found in soil and water. After initial antibiotics failed, doctors identified the fungus and switched to an antifungal medication called voriconazole. By carefully monitoring drug levels in the patient’s blood and adjusting doses, pharmacists helped achieve a successful recovery with complete resolution of symptoms.

Read More »

Bioactive Properties of Selected European Phellinus Species: A Comprehensive Study

mycolabadmin

This research examined 30 samples of medicinal mushrooms from the Phellinus genus collected across Europe, including Poland, Italy, Portugal, Kosovo, and North Macedonia. Scientists found that three species—Phellinus igniarius, Fomitiporia robusta, and Porodaedalea pini—are particularly rich in beneficial compounds, especially polysaccharides and antioxidants. These mushroom extracts showed impressive abilities to fight antibiotic-resistant bacteria and protect cells from oxidative damage, suggesting they could become valuable sources for new medicines and functional foods.

Read More »

Fungal peritonitis in a patient on peritoneal dialysis caused by Hyphopichia burtonii: A rare pathogen in human infection

mycolabadmin

A woman undergoing peritoneal dialysis for kidney failure developed a serious fungal infection caused by a rare yeast called Hyphopichia burtonii. Doctors identified the infection using advanced laboratory techniques and treated her with antifungal medication after removing her dialysis catheter. She recovered well and switched to a different type of dialysis. This case highlights how unusual fungi can cause infections in patients with weakened kidney function.

Read More »

A Case of Sphenoid Sinusitis With Epidural Abscess due to Fungal Infection and Mixed Infection With Eikenella corrodens and Aggregatibacter segnis

mycolabadmin

A 60-year-old woman developed a severe headache caused by a fungal and bacterial infection in her sphenoid sinus (located deep in the skull). The infection spread intracranially, creating an abscess. Doctors used imaging scans to diagnose the problem, performed surgery to drain the infection and remove the fungal material, and treated the patient with antibiotics. The patient recovered completely with no recurrence after four years.

Read More »

Clinical insights into mixed Candida and bacterial bloodstream infections: a retrospective cohort study

mycolabadmin

This study found that when both Candida fungus and bacteria are present together in a patient’s bloodstream, the outcome is much more serious than when only Candida is present. Among patients with these mixed infections, over 60% died within 30 days compared to about 52% for those with only Candida. The research shows that giving the right antibiotics early and following proper treatment guidelines can significantly improve survival chances in these severe, life-threatening infections.

Read More »
Scroll to Top